Investor Video Call // March 04, 2026 // 2:00 p.m. CET
Q4/Fiscal Year 2025 Results
Bayer delivers upgraded 2025 ambition, projects solid 2026, focused on strategic priorities
Download Investor Video Call Materials
Speakers
Bill AndersonChairman | Wolfgang NicklFinance | Stefan OelrichPharmaceuticals | Rodrigo SantosCrop Science | Julio TrianaConsumer Health |
Investor Services
Subscribe to our newsletter for regular financial updates or contact our team directly via e-mail for any individual inquiries.